The radiotherapy device market is expected to reach USD 7,733.4 million by 2025 and is expected to steadily grow at a CAGR of 6.6% to reach USD 14,653.5 million by 2035. In 2024, radiotherapy device market have generated roughly USD 7,254.6 million in revenues.
A radiation therapy apparatus is a cancer treatment device primarily used for localized tumors. Such appliances include a variety of technological utilities, including linear accelerators (linac), proton therapy devices, and brachytherapy devices. Radiotherapy equipment demand continues to rise due to several factors. First, the increasing incidence of cancer worldwide is pushing the need for such advanced treatment systems.
The technologies used for treating cancer, such as image-guided radiotherapy (IGRT) and intensity-modulated radiation therapy (IMRT), are all providing an accuracy improvement in treatment results, thus making them attractive to medical practitioners. Similarly, awareness of non-invasive cancer treatment is being increased, as many governments operate various schemes to upgrade oncology treatment facilities, which will continue to induce adoption.
Key Market Metrics
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 7,733.4 million |
| Industry Value (2035F) | USD 14,653.5 million |
| CAGR (2025 to 2035) | 6.6% |
A number of historical events contributed towards fast-tracking the saturation of radiotherapy machines in the years between 2020 and 2024. Covid-19 brought out the essential aspects of non-surgical oncology treatments since hospitals focused on surgical treatment but to the least possible patient limits in outpatient treatment to minimize exposure risks in infection. This increased the demand for greater sophistication in radiotherapy equipment.
Further, technology at the time also advanced in areas such as artificial intelligence (AI) used in planning treatment, real-time imaging advancements, and improved accuracy by adaptive radiotherapy. All these features improved the efficiency and attractiveness of radiotherapy machines for healthcare practitioners.
National governments also upped the stakes in investments toward cancer care facilities through national cancer programs and, thus, increased contemporary installations of radiotherapy machines. Rising cancer incidence across many countries accompanied by the aging population also hastened the demand for better treatment processes.
Explore FMI!
Book a free demo
With such technological advancements made in real-time tumor tracking, image-guided radiotherapy (IGRT), and new insights into proton therapy, a more precise mode of treatment enables far more hospitals and cancer treatment centers to equip their facilities with new technology. Favorable reimbursement policies and government support will further enhance the adoption of technologies.
Well-established radiotherapy equipment manufacturing companies alongside strong partnerships between research institutions and technology companies for innovation and implementation will also benefit this market. This is also supported by increased awareness of advanced cancer therapies and personalized treatments.
Radiotherapy device demand is rising in Europe due mainly to the increasing cancer burden and focus on improving cancer care infrastructure in that region. European countries are adding investment priority to advanced radiotherapy technologies under their National Cancer Plans.
Newer systems are coming into the hospitals from these advancements in technology, such as adaptive radiotherapy, proton therapy, and AI-based treatment planning, increasing accuracy and benefits for patients. Additional demand for outpatient and non-invasive approaches to cancer treatment enables the implementation of advanced radiotherapy applications. Meanwhile, close collaboration between the radiotherapy manufacturers and the European centers of oncology research encourages innovations that further promote uptake across the region.
Asia-Pacific countries are experiencing rising trends in radiotherapy device sales due to the rising incidences of cancer, increased spending on health care, and increased access to high-end medical technologies. In countries like China, Japan, and India, cancer cases continue to rise with rapid urbanization, increasing living standards, and lifestyles that put patients under the effectiveness of living within standards that call for effective radiotherapy treatment.
The government in this area also invests in cancer care construction with more oncology centers and improved reimbursement policies, leading health facilities to acquire new radiotherapy machines. The collaborations between global manufacturers and local players are also creating more availability of products further increasing sales.
Challenges
High Cost associated with Maintaining Advanced Radiotherapy Systems Hinder its Adoption in the Market
The outlay on advanced systems for radiotherapy, especially those employing proton therapy and adaptive radiotherapy, is often a crippling expense for small hospitals and health centers, especially in the developing part of the world. The infrastructure requirements, such as radiation-protected treatment rooms, only add costs. Additionally, heavy training for practicing oncologists, radiologists, and technicians on operating such advanced systems is an added cost to the operational cost.
The restricted reimbursement policy for some of the new radiotherapy technologies in various countries remains another hindrance. Expenditure and workload slow down the adoption of radiotherapy in countries with strapped healthcare budgets, leading to the denial of availability of these life-saving therapies by the majority of cancer patients.
Opportunities
Increase in adoption of Hypofractionated Radiotherapy and Outpatient Treatment models Poses new Opportunities in the Market
A prime prospect for the sale of radiotherapy machines lies in the burgeoning use of hypofractionated radiotherapy and outpatient treatment programs. This means larger doses of radiation per visit under hypofractionation, greatly reducing treatment visits for patients. This not only adds to patient comfort but also helps the operation of the treatment facility for increased patient turnover within the same period.
This situation becomes increasingly important in regions where cancer incidence is high and radiotherapy capacity is low. Outpatient cancer treatment, resulting from pressure of cost containment and patient demand for less intrusive treatments, is benefitting modern advanced radiotherapy systems that allow for short, targeted treatment schedules.
This is accelerating investment by hospitals and oncology clinics in high throughput, modern radiotherapy equipment, thereby sustaining demand for technologically advanced but cost-effective systems across the globe.
Technological Advancements is Transforming the Radiotherapy Device Market
Image-guided radiotherapy (IGRT), adaptive radiotherapy, and proton beam therapy are technological approaches that elevate the precision yet minimise radiation unwantedly to the healthy tissue, thus allowing clinicians to treat tumors. Today's devices include real-time imaging and motion management to track patient movements while automatically adjusting delivery of radiation; hence it ultimately improves safety and efficacy.
Rising Global Cancer Incidence Fuels Device Demand
The increasing number of cases predicates an equally increasing demand for effective localized cancer treatments, among which radiotherapy stands in the lead. Accordingly, the healthcare systems of developed economies, say, Europe and North America, are being loaded out with next-generation radiotherapy systems, as the patient load limits the use of older radiotherapy equipment together with the integration of advanced treatment modalities.
We are also witnessing a rush from the developing world, showing increasing commitment to the provision of cancer treatment facilities for implementation of economical radiotherapy systems, thereby enhancing access to advanced cancer therapy.
Expansion of Proton Therapy Centers Shapes the Future of Radiotherapy Device Treatments
increasing utility of proton therapy systems, especially in sophisticated cancer centers, is an emerging trend that is transforming the radiotherapy device market. Proton therapy possesses the upper hand in terms of dose accuracy as it provides several dosages hitting the tumor directly and protects the decent surrounding tissue from excessive irradiation, which is pinpoint beneficial in the cure of certain pediatric malignancies, brain tumors, and other demanding cases requiring high precision.
The increasing demonstration of efficacy in certain tumor conditions as predicted from the patients who have undergone the treatment and shown improvement, proton therapy will start gaining so much success that it will completely turn out to be the frontline radiotherapy technique,
Rising Demand for Biocompatible and Sustainable Materials is Emerging as a Key Trend in Dental Caries And Endodontic Treatments
increasing with the inclusion of superior imaging technologies into the radiotherapy devices themselves and the use of real-time tumor visualization and treatment correction. Movements of a tumor due to different bodily activities like respiration, swallowing, or body-location changes will benefit from cone-beam CBCTs, MR-guided radiotherapy or 4D imaging onboard.
These technologies allow for monitoring of the tumors in the treatment area, which, in turn, allows for the modulation of radiation delivery according to real-time tumor position, thereby greatly increasing accuracy with the minimum collateral damage to surrounding normal tissues. Placing imaging and treatments together into one box, building radiotherapy appliances are evolving into downright smart adaptive systems while holding the line with the concept of personalized, image-guided cancer therapy
The market of the radiotherapy devices continued to grow steadily from 2020 to 2024, owing to the increasing global cancer burden, technological advances, and investments in oncology infrastructure. Between 2025 and 2035, it will gain an extraordinary amount of traction through AI treatment planning innovations, uptake of hypofractionated therapy, and furthering treatment access to proton therapy.
In addition to the growth of cancer screening programs, particularly in developing economies, demand for custom image-guided treatments will provide further impetus to innovation and adoption, placing radiotherapy devices at the very heart of end-to-end cancer care strategies across the globe..
| Category | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Regulatory bodies including the FDA and EMA intended to implement precision-safe patient protection systems for radiation equipment, placing especially high demands on dose accuracy and data security harnessed in the digital technologies. |
| Technological Advancements | In 2020 and across to 2024, advancement priorities for the main developments literally revolved around image-guided radiotherapy (IGART); motion management technologies and adoption of hypofractionated and stereotactic treatments were expected to tumble into this category during the same period. |
| Consumer Demand | High incidence of cancers and awareness of high-end treatment capabilities with increased patient pressure for shorter treatment schedules which drives the demand for hypofractionation-capable and image-guided radiotherapy equipment |
| Market Growth Drivers | an increase in cancer treatment facilities, and a quick pace of technological advancements in developed hospitals. These public-private collaborations have also opened up avenues for accessing state-of-the-art radiotherapy |
| Sustainability | It began to appear in related contexts like those of creating energy-saving equipment and reducing waste in consumables such as shielding materials and applicators under sustainability programs in a radiotherapy facility. |
| Category | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Harmonising international regulations may in turn simplify the approval processes for taking up technologies in emerging markets |
| Technological Advancements | Radiotherapy machines by 2035 will be equipped with real-time AI-based adaptive therapy, MRI-linac hybrids, and intelligent treatment planning software that together provide ultra-accurate, fast, and personalized cancer treatments for different tumors |
| Consumer Demand | The Incidents of cancer will increase as the population ages and lifestyle factors change, which will be accompanied by growing demands from patients for outpatient-friendly, AI-based radiotherapy systems tailored to their personal needs |
| Market Growth Drivers | Access to advanced radiotherapy in emerging markets, increased uptake of proton therapy, and the integration of radiotherapy into a complete cancer care network will enhance the growth of the market during the period 2025 to 2035. Funding for cancer screening programs would go along in raising the demand |
| Sustainability | In 2035, radiotherapy equipment manufacturers would develop a green initiative in producing energy-efficient linear accelerators in addition to recyclable or biodegradable patient immobilisation materials to make oncology departments greener around the globe. |
High cancer incidence rates, continuous innovations made by big names in the industry, and reimbursements that favor for radiotherapy equipment promises a bright future for the USA market. Increased investments in treatment planning by means of artificial intelligence, hypofractionated radiotherapy, and the addition of many proton therapy centers will extend this market reach.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 3.2% |
Public healthcare funding in Germany is strong, coupled with lead research in oncology and high implantation of precision technologies such as MRI-guided radiotherapy into treatment protocols. Their rise is further boosted by growing interests in national cancer screening programs and increased proton therapy centers while an aging population continues to demand sophisticated cancer treatment solutions.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Germany | 4.4% |
Growth in India's radiotherapy equipment market is fueled primarily by the steadily increasing prevalence of cancer, government spending on cancer care facility setups, and awareness about new treatment techniques. Other factors contributing to the growth include public-private partnerships, development of tertiary hospitals, and affordable radiotherapy treatments for smaller towns and rural health facilities.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 4.2% |
Intense hospital infrastructure development, rising cancer burden, and government-driven therapeutic developments in oncology help China's radiotherapy device market. Increased attention toward in-country manufacture of sophisticated radiotherapy devices and high-demand precision treatment such as proton therapy predestine China at the horizon for the best growth region for both Chinese and international players.
Market Growth Drivers
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| China | 5.1% |
The rapid aging of the population in Japan, the high cancer screenings, and early introduction of newer technologies such as proton and carbon ion therapy have all galvanized the radiotherapy equipment market. Coupled with government initiatives for advanced oncology research and the emphasis on minimal invasive cancer therapies will accrue steady growth to the market by 2035.
Market Growth Drivers
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 4.8% |
External Beam Radiation Therapy (EBRT) devices dominate the Radiotherapy Device Market due to their Versatility, Non-Invasiveness, And Wide Applicability
EBRT ensures precision in targeting tumors while simultaneously sparing normal tissues, which plays a key role in improving patient outcomes. The recent advances in this field, including image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), and proton therapy, further improve the efficacy and safety of EBRT. Finally, its acceptance in outpatient settings, higher patient throughput, and reimbursement coverage have made EBRT systems a top favorite among healthcare institutions, thus allowing their global market leadership.
Internal Beam Radiation Therapy (IBRT) holds a significant share in the Radiotherapy Device Market Due to its Highly Localized Delivery
Internal Beam Radiation Therapy (IBRT), namely brachytherapy, has a large share in the radiotherapy device market from localized delivery, making it especially applicable for treatment of gynecological, prostate, or cervical cancers. This localized delivery permits doctors to deliver high doses of radiation directly to the tumor with consequent low dose to the surrounding tissues.
Brachytherapy devices are small and inexpensive and are sometimes used in an outpatient setting; therefore, they are accessible. Very few external beam radiation treatments are done without brachytherapy augmentations in combination treatments, enhancing the demand for brachytherapy. Modern innovations such as real-time imaging guidance and patient-specific applicators increase segment value for contemporary oncologic therapy.
Hospitals Segment dominate the Radiotherapy Device market due to their comprehensive Care Specialties
The hospitals segment dominates the market for radiotherapy devices due to completely available cancer care facilities and availability of advanced radiotherapy technologies. The biggest investment-making hospitals such as tertiary hospitals spend on advanced radiotherapy devices such as linear accelerators, proton therapy systems, and image-guided platforms.
High patient volume makes hospitals a one-stop center for both diagnostic and therapeutic services, thus making the hospital the prime choice for a cancer patient. This also makes radiotherapy devices a common end-user for hospitals in the global radiotherapy device market due to positive reimbursement policies, multidisciplinary cancer teams, and clinical trial infrastructure.
Rising Demand for Specialized And Dedicated Cancer Care Facilities aid it to Grow at Significant Growth Rate
The oncology treatment centers are rapidly emerging within the equipment segment of radiotherapy as more people require specialist and dedicated centers for cancer care. The centers care for the patients by specializing only in cancer diagnosis treatment and follow-up to offer super specialization and quicker access to radiotherapy.
With rising incidences of cancer, growing free-standing centers have proliferated in both developed and developing regions often associated with public health programs for enhanced access. Increased access is further accentuated through improved small radiotherapy machines best suitable for dedicated cancer centers. In addition, there is an increasing preference among patients for specialized centers mainly to receive novel therapies such as proton therapy, which leads to this segment's healthy growth.
The Radiotherapy Devices market continues to be competitive, with increasing cancer incidence and rising interest in precision oncology. The competition is being led by tech innovations in adaptive radiotherapy, AI-driven treatment planning, and integration of real-time imaging for better accuracy and fewer side effects.
Companies are investing in the efficiency of treatment through proton therapy systems, small linear accelerators meant for outpatient/mobile applications, and automated workflow solutions. These factors all together attribute to the growth of the market.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Varian Medical Systems, Inc. | 34.6% to 38.5% |
| Koninklijke Philips N.V. | 20.4% to 22.6% |
| Elekta | 15.1% to 17.2% |
| Accuray Incorporated | 4.6% to 6.8% |
| Other Companies (combined) | 12.1% to 15.4% |
| Company Name | Key Offerings/Activities |
|---|---|
| Varian Medical Systems | Varian engages in the latest linear accelerators (LINACs), image-guided radiotherapy (IGRT), and proton therapy systems. Both linear accelerators and image-guided radiotherapy are heavily integrated with cancer treatment centers in developing treatment planning software and adaptive radiotherapy platforms for the personalized treatment of cancer. |
| RefleXion | RefleXion is advanced in biology-guided radiotherapy, combining PET imaging and real-time tumor imaging with radiotherapuetic technique. |
| Elekta | Elekta supplies precise radiotherapy technology with strong emphasis on workflow automation and integration of real-time imaging. Stereotactic radiosurgery (SRS) and brachytherapy devices form the main part of Elekta's range |
| Accuray Incorporated | Accuray directly focuses on robotic radiosurgery systems (CyberKnife) as well as helical tomotherapy (TomoTherapy) being rather particular on non-invasive accuracy |
Key Company Insights
Varian Medical Systems, Inc.
Varian holds the leadership position in the entire radiotherapy domain, with a full portfolio concerning linear accelerators, proton therapy, and adaptive radiotherapy coupled with AI. Its end-to-end oncology solutions in solid clinical collaboration and international service also serve to cement its leadership in the market
Elekta
Elekta has gained a defined identity in so far as MRI-guided radiotherapy is concerned through: Elekta Unity and its integrated oncology software suite. Its thrust into Cloud-based remote planning and its touch on adaptive precision radiotherapy also increased its presence worldwide
Accuray Incorporated
Accuray manages the most mature product in the highest category of radiosurgery today with CyberKnife® and Tomo Therapy®, dominating motion tracking and adaptive delivery.
Other Key Players
The overall market size for radiotherapy device market was USD 7,733.4 million in 2025.
The radiotherapy device market is expected to reach USD 14,653.5 million in 2035.
Growing innovation in software for treatment planning and monitoring anticipates the growth of the medical bionic implant and artificial organs market.
The top key players that drives the development of radiotherapy device market are Varian Medical Systems, Inc., Koninklijke Philips N.V., Elekta, Accuray Incorporated and Siemens AG.
External beam radiation therapy device segment by product is expected to dominate the market during the forecast period.
External Beam Radiation Therapy Device (Linear Accelerators Device and Proton Therapy Device), Internal Beam Radiation Therapy Device (Brachytherapy Device and Others)
Hospitals, Ambulatory Surgical Centers and Oncological Treatment Centers
Epidemic Keratoconjunctivitis Treatment Market Overview – Growth, Trends & Forecast 2025 to 2035
Eosinophilia Therapeutics Market Insights – Trends & Forecast 2025 to 2035
Endometrial Ablation Market Analysis - Size, Share & Forecast 2025 to 2035
Endotracheal Tube Market - Growth & Demand Outlook 2025 to 2035
Encephalitis Treatment Market - Growth & Future Trends 2025 to 2035
Edward’s Syndrome Treatment Market – Growth & Future Prospects 2025 to 2035
Radiotherapy Device Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
